Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Quarterly results Director departure
|
TENAX THERAPEUTICS, INC. (TENX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/09/2023 |
SC 13D/A
| Rich Stuart reports a 2.3% stake in Tenax Therapeutics, Inc. |
02/09/2023 |
SC 13D/A
| Doogan Declan reports a 2% stake in Tenax Therapeutics, Inc. |
01/06/2023 |
SC 13D/A
| Rich Stuart reports a 9.4% stake in Tenax Therapeutics, Inc. |
01/06/2023 |
SC 13D/A
| Doogan Declan reports a 7.9% stake in Tenax Therapeutics, Inc. |
09/23/2022 |
SC 13D/A
| Rich Stuart reports a 14.3% stake in Tenax Therapeutics, Inc. |
08/12/2022 |
SC 13D/A
| Doogan Declan reports a 14.4% stake in Tenax Therapeutics, Inc. |
06/17/2022 |
SC 13D/A
| ARMISTICE CAPITAL, LLC reports a 10% stake in Tenax Therapeutics, Inc. |
05/20/2022 |
SC 13D/A
| ARMISTICE CAPITAL, LLC reports a 10% stake in Tenax Therapeutics, Inc. |
12/06/2021 |
SC 13D/A
| Rich Stuart reports a 17% stake in Tenax Therapeutics, Inc. |
08/24/2021 |
SC 13D/A
| Doogan Declan reports a 14.4% stake in Tenax Therapeutics, Inc. |
07/09/2021 |
SC 13D/A
| ARMISTICE CAPITAL, LLC reports a 10% stake in Tenax Therapeutics, Inc. |
06/02/2020 |
SC 13D/A
| Binsalamah Ziyad reports a 0% stake in Tenax Therapeutics, Inc. |
|
|